McGill IBD logo
Donate

MUHC Activities

Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk
Lee SH, Turpin W, Espin-Garcia O, Raygoza Garay JA, Smith MI, Leibovitzh H, Goethel A, Turner D, Mack D, Deslandres C, Cino M, Aumais G, Panaccione R, Jacobson K, Bitton A, Steinhart AH, Huynh HQ, Princen F, Moayyedi P, Griffiths AM, Silverberg MS, Paterson AD, Xu W, Croitoru K; Crohn’s and Colitis Canada Genetics Environment Microbial Project Research Consortium.Gastroenterology. 2021 Jul 20:S0016-5085(21)03243-1. doi: 10.1053/j.gastro.2021.07.009. Online ahead of print. PMID: 34293299

Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study.
Kuenzig ME, Bitton A, Carroll MW, Kaplan GG, Otley AR, Singh H, Nguyen GC, Griffiths AM, Stukel TA, Targownik LE, Jones JL, Murthy SK, McCurdy JD, Bernstein CN, Lix LM, Peña-Sánchez JN, Mack DR, Jacobson K, El-Matary W, Dummer TJB, Fung SG, Spruin S, Nugent Z, Tanyingoh D, Cui Y, Filliter C, Coward S, Siddiq S, Benchimol EI; Canadian Gastro-Intestinal Epidemiology Consortium.J Crohns Colitis. 2021 Jun 27:jjab113. doi: 10.1093/ecco-jcc/jjab113. Online ahead of print.PMID: 34175936

Serum Analyte Profiles Associated With Crohn’s Disease and Disease Location.
Boucher G, Paradis A, Chabot-Roy G, Coderre L, Hillhouse EE, Bitton A, Des Rosiers C, Levings MK, Schumm LP, Lazarev M, Brant SR, Duerr R, McGovern D, Silverberg MS, Cho J, Lesage S, Rioux JD; iGenoMed Consortium; NIDDK IBD Genetics Consortium.Inflamm Bowel Dis. 2021 Jun 9:izab123. doi: 10.1093/ibd/izab123. Online ahead of print.PMID: 34106269

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI.J Can Assoc Gastroenterol. 2021 Jul 29;4(4):e72-e91. doi: 10.1093/jcag/gwab016. eCollection 2021 Aug.PMID: 34476339 .

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Benchimol EI, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Jones JL.J Can Assoc Gastroenterol. 2021 Jul 29;4(4):e59-e71. doi: 10.1093/jcag/gwab015. eCollection 2021 Aug.PMID: 34476338.

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI. 2021 Aug;161(2):681-700. doi: 10.1053/j.gastro.2021.04.034. PMID: 34334167

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Benchimol EI, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Jones JL. 2021 Aug;161(2):669-680.e0. doi: 10.1053/j.gastro.2020.12.079. Epub 2021 Feb 19. PMID: 33617891

Subcutaneously Administered Anti-TNFs for the Treatment of Ulcerative Colitis: A Retrospective, Propensity Score-Matched, US Health Claims Analysis. Stewart MJ, Bessissow T, Gregor J, Hazel M, In TSH, Karra K, Dajnowiec D, Williamson M, Sattin B.Adv Ther. 2021 Jul;38(7):4115-4129. doi: 10.1007/s12325-021-01818-3. Epub 2021 Jun 22.PMID: 34159558

Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study. McCurdy JD, Reid J, Yanofsky R, Sinnathamby V, Medawar E, Williams L, Bessissow T, Rosenfeld G.Inflamm Bowel Dis. 2021 May 14:izab086. doi: 10.1093/ibd/izab086. Online ahead of print. PMID: 33988225

Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitis. Peng X, Isnard S, Lin J, Fombuena B, Bessissow T, Chomont N, Routy JP.J Virus Erad. 2021 Feb 15;7(1):100033. doi: 10.1016/j.jve.2021.100033. eCollection 2021 Mar. PMID: 33664976

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report. Costiniuk CT, Bessissow T, Isnard S, Routy JP.Oxf Med Case Reports. 2021 Jan 23;2021(1):omaa131. doi: 10.1093/omcr/omaa131. eCollection 2021 Jan.PMID: 33542833

Clinical Guidelines for the Management of Inflammatory Bowel Disease. Khanna R, Wilson AS, Gregor JC, Prowse KL, Afif W. 2021 Sep 14:S0016-5085(21)03521-6. doi: 10.1053/j.gastro.2021.09.021. Online ahead of print.PMID: 34534537 No abstract available.

Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial. Afif W, Sattin B, Dajnowiec D, Khanna R, Seow CH, Williamson M, Karra K, Wang Y, Gao LL, Bressler B.Dig Dis Sci. 2021 Aug 17. doi: 10.1007/s10620-021-07173-1. Online ahead of print.PMID: 34401983

A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. Cheifetz AS, Abreu MT, Afif W, Cross RK, Dubinsky MC, Loftus EV Jr, Osterman MT, Saroufim A, Siegel CA, Yarur AJ, Melmed GY, Papamichael K.Am J Gastroenterol. 2021 Aug 13. doi: 10.14309/ajg.0000000000001396. Online ahead of print.PMID: 34388143

Effectiveness of Third-Class Biologic Treatment in Crohn’s Disease: A Multi-Center Retrospective Cohort Study. Albshesh A, Taylor J, Savarino EV, Truyens M, Armuzzi A, Ribaldone DG, Shitrit AB, Fibelman M, Molander P, Liefferinckx C, Nancey S, Korani M, Rutka M, Barreiro-de Acosta M, Domislovic V, Suris G, Eriksson C, Alves C, Mpitouli A, di Jiang C, Tepeš K, Coletta M, Foteinogiannopoulou K, Gisbert JP, Amir-Barak H, Attauabi M, Seidelin J, Afif W, Marinelli C, Lobaton T, Pugliese D, Maharshak N, Cremer A, Limdi JK, Molnár T, Otero-Alvarin B, Krznaric Z, Magro F, Karmiris K, Raine T, Drobne D, Koutroubakis I, Chaparro M, Yanai H, Burisch J, Kopylov U.J Clin Med. 2021 Jun 29;10(13):2914. doi: 10.3390/jcm10132914.PMID: 34209880

Providing Hospitalized Ulcerative Colitis Patients With Practice Guidelines Improves Patient-Reported Outcomes. Weizman AV, Bressler B, Seow CH, Afif W, Afzal NM, Targownik L, Nguyen DM, Jones JL, Huang V, Murthy SK, Nguyen GC.J Can Assoc Gastroenterol. 2020 Jun 9;4(3):131-136. doi: 10.1093/jcag/gwaa019. eCollection 2021 Jun.PMID: 34061122

Novel Negative Pressure Protective Box in Upper Digestive Endoscopy: A Prospective Case Series. Benmassaoud A, Bessissow T, Wong P, Fallone CA, Barkun A, Afif W, Forbes N, Martel M, Geraci O, Chen YI.Am J Gastroenterol. 2021 Jun 1;116(6):1339-1341. doi: 10.14309/ajg.0000000000001221.PMID: 33734112

Ustekinumab for Ulcerative Colitis. Khanna R, Afif W. 2021 May;160(6):2184-2186. doi: 10.1053/j.gastro.2021.02.002. Epub 2021 Feb 4.PMID: 33548233

Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn’s Disease. Verdon C, Vande Casteele N, Heron V, Germain P, Afif W.J Can Assoc Gastroenterol. 2020 Mar 31;4(2):73-77. doi: 10.1093/jcag/gwaa003. eCollection 2021 Apr.PMID: 33855264

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease. Restellini S, Afif W.J Clin Med. 2021 Mar 17;10(6):1242. doi: 10.3390/jcm10061242. PMID: 33802816

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring. Albader F, Golovics PA, Gonczi L, Bessissow T, Afif W, Lakatos PL. World J Gastroenterol. 2021 Oct 7;27(37):6231-6247. doi: 10.3748/wjg.v27.i37.6231. PMID: 34712029

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro-Sanchez M, Czuber-Dochan W, Eder P, Ellul P, Fidalgo C, Fiorino G, Gionchetti P, Gisbert JP, Gordon H, Hedin C, Holubar S, Iacucci M, Karmiris K, Katsanos K, Kopylov U, Lakatos P, Lytras T, Lyutakov I, Noor N, Pellino G, Piovani D, Savarino E, Selvaggi F, Verstockt B, Spinelli A, Panis Y, Doherty G. J Crohns Colitis. 2021 Oct 12:jjab178. doi: 10.1093/ecco-jcc/jjab178. Online ahead of print. PMID: 34635919

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro-Sanchez M, Czuber-Dochan W, Eder P, Ellul P, Fidalgo C, Fiorino G, Gionchetti P, Gisbert JP, Gordon H, Hedin C, Holubar S, Iacucci M, Karmiris K, Katsanos K, Kopylov U, Lakatos P, Lytras T, Lyutakov I, Noor N, Pellino G, Piovani D, Savarino E, Selvaggi F, Verstockt B, Spinelli A, Panis Y, Doherty G. J Crohns Colitis. 2021 Oct 12:jjab178. doi: 10.1093/ecco-jcc/jjab178. Online ahead of print. PMID: 34635910

The Burden of Inflammatory Bowel Disease in Europe in 2020. Zhao M, Gönczi L, Lakatos PL, Burisch J.J Crohns Colitis. 2021 Sep 25;15(9):1573-1587. doi: 10.1093/ecco-jcc/jjab029.PMID: 33582812

Incidence, Predictive Factors, Clinical Characteristics and Outcome of Non-variceal Upper Gastrointestinal Bleeding – A Prospective Population-based Study from Hungary. Lakatos L, Gonczi L, Lontai L, Izbeki F, Patai A, Racz I, Gasztonyi B, Varga-Szabo L, Ilias A, Lakatos PL.J Gastrointestin Liver Dis. 2021 Sep 21;30(3):327-333. doi: 10.15403/jgld-3495.PMID: 34375379

[Outcomes of variceal upper gastrointestinal bleeding: A prospective, multicenter, population-based study from West Hungary]. Lakatos L, Gönczi L, Izbéki F, Patai Á, Rácz I, Gasztonyi B, Varga-Szabó L, Barnabás Á, Iliás Á, Lakatos PL.Orv Hetil. 2021 Aug 1;162(31):1252-1259. doi: 10.1556/650.2021.32166.PMID: 34333456 Hungarian.

Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort. Al Khoury A, Xiao Y, Golovics PA, Kohen R, Afif W, Wild G, Friedman G, Galiatsatos P, Hilzenrat N, Szilagyi A, Wyse J, Cohen A, Bitton A, Bessissow T,Lakatos PL.Dig Liver Dis. 2021 Aug;53(8):980-986. doi: 10.1016/j.dld.2021.02.006. Epub 2021 Feb 24.PMID: 33640302

Clinical efficacy, drug sustainability and serum drug levels in Crohn’s disease patients treated with ustekinumab – A prospective, multicenter cohort from Hungary. Gonczi L, Szanto K, Farkas K, Molnar T, Szamosi T, Schafer E, Golovics PA, Barkai L, Lontai L, Lovasz B, Juhasz M, Patai A, Sarang K, Vincze A, Sarlos P, Farkas A, Dubravcsik Z, Toth TG, Miheller P, Ilias A, Lakatos PL.Dig Liver Dis. 2021 Jul 31:S1590-8658(21)00377-7. doi: 10.1016/j.dld.2021.07.008. Online ahead of print.PMID: 34344576

Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study. Golovics PA, Gonczi L, Reinglas J, Verdon C, Pundir S, Afif W, Wild G, Bitton A, Bessissow TLakatos PL.Dig Dis Sci. 2021 Jul 20. doi: 10.1007/s10620-021-07178-w. Online ahead of print.PMID: 34286411

Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle. Restellini S, Lakatos PL.J Crohns Colitis. 2021 Jul 5;15(7):1085-1086. doi: 10.1093/ecco-jcc/jjaa261.PMID: 33515244 No abstract available.

Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters! Wetwittayakhlang P, Lakatos PL.J Crohns Colitis. 2021 Jun 7:jjab084. doi: 10.1093/ecco-jcc/jjab084. Online ahead of print.PMID: 34096579 No abstract available.

Reply. Hirten RP, Lakatos PL, Halfvarson J, Colombel JF.Clin Gastroenterol Hepatol. 2021 Jun;19(6):1301-1302. doi: 10.1016/j.cgh.2020.07.061. Epub 2020 Nov 26.PMID: 33248096 No abstract available.

Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Al Khoury A, Balram B, Bessissow T, Afif W, Gonczi L, Abreu M, Lakatos PL.Dig Dis Sci. 2021 May 21:1-19. doi: 10.1007/s10620-021-07025-y. Online ahead of print.PMID: 34021425

Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Santella C, Bitton A, Filliter C, Bessissow T, Vutcovici M, Lakatos PL, Brassard P.Inflamm Bowel Dis. 2021 May 17:izab092. doi: 10.1093/ibd/izab092. Online ahead of print.PMID: 33999136

Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy. Balram B, Lubov J, Theoret Y, Afif W, Bitton A, Wild G, Lakatos PL, Bessissow T.Dig Dis Sci. 2021 May;66(5):1650-1657. doi: 10.1007/s10620-020-06427-8. Epub 2020 Jun 26.PMID: 32591969

No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015. Verdon C, Reinglas J, Coulombe J, Gonczi L, Bessissow T, Afif W, Vutcovici M, Wild G, Seidman EG, Bitton A, Brassard P, Lakatos PL.Inflamm Bowel Dis. 2021 Apr 15;27(5):655-661. doi: 10.1093/ibd/izaa166.PMID: 32676662

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC; International Organization for the Study of Inflammatory Bowel Disease (IOIBD) (Lakatos PL); International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). 2021 Apr;70(4):635-640. doi: 10.1136/gutjnl-2020-324000. Epub 2021 Jan 20.PMID: 33472895 Free PMC article.No abstract available.

Subjective expectations regarding longevity and future health: a cross-sectional survey among patients with Crohn’s disease. Péntek M, Gulácsi L, Herszényi L, Banai J, Palatka K, Lakatos PL, Brodszky V, Rencz F.Colorectal Dis. 2021 Jan;23(1):105-113. doi: 10.1111/codi.15357. Epub 2020 Oct 13.PMID: 32920967

Your donations help deliver specialized and quality care to people with inflammatory bowel disease (IBD) in Quebec.

Your generosity benefits the IBD clinics at the Montreal General Hospital, the Montreal Children's Hospital and the Jewish General Hospital.

Donate